KYTX ▼ -0.4% - Kyverna Therapeutics, Inc.
$KYTX Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis
24-SEP-2026 06:02 AM ET
Share this post
More filings for $KYTX
KYTX ▲ +1.6% - Kyverna Therapeutics, Inc.Sep 24, 2026KYTX ▲ +2.9% - Kyverna Therapeutics, Inc.Sep 2, 2026KYTX - Kyverna Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$KYTX SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026
View full $KYTX filing history →💬 Comments
Loading comments…
Leave a comment